Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$1.76 - $2.83 $2.47 Million - $3.97 Million
1,404,038 New
1,404,038 $3.55 Million
Q4 2022

Feb 14, 2023

BUY
$2.05 - $3.47 $269,324 - $455,881
131,378 Added 38.45%
473,084 $1.19 Million
Q3 2022

Nov 14, 2022

BUY
$0.63 - $5.47 $171,118 - $1.49 Million
271,617 Added 387.53%
341,706 $991,000
Q2 2022

Aug 15, 2022

SELL
$4.27 - $8.26 $329,823 - $638,018
-77,242 Reduced 52.43%
70,089 $317,000
Q1 2022

May 09, 2022

BUY
$7.07 - $11.62 $534,067 - $877,774
75,540 Added 105.22%
147,331 $1.18 Million
Q4 2021

Feb 01, 2022

BUY
$10.49 - $14.28 $753,087 - $1.03 Million
71,791 New
71,791 $836,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.